scholarly journals Expediency of application of animals with the spontaneous hypertensia for modelling of the metabolic syndrome

2012 ◽  
Vol 10 (4) ◽  
pp. 91-94
Author(s):  
Maria Alexandrovna Kovaleva ◽  
Marina Nikolayevna Makarova ◽  
A. I. Selezneva ◽  
Valeriy Gennadyevich Makarov
Keyword(s):  
Metabolic Syndrome ◽  
Visceral Obesity ◽  
Cafeteria Diet ◽  
Blood Concentrations ◽  
Spontaneously Hypertensive ◽  
The Metabolic Syndrome ◽  
Calorie Diet ◽  
Wistar Kyoto ◽  
High Calorie Diet ◽  
High Calorie

When used within 11 weeks of diet “cafeteria diet” in spontaneously-hypertensive animals could lead to an increase in systolic blood pressure by 9%, sustained hyperglycemia, increased blood concentrations of triglycerides and cholesterol, as well as an increase in the relative content of visceral fat. In normotensive animals line Wistar-Kyoto prolonged use of “cafeteria diet” was accompanied only by an increase in blood glucose, cholesterol and triglycerides. Thus, the spontaneously hypertensive animals, the application of high-calorie diet demonstrated by three criteria pathogenesis of the metabolic syndrome: hyperglycemia, hypertension and visceral obesity, which allows you to use the model for the study of drugs aimed at treatment of metabolic syndrome.

scholarly journals MORPHOMETRIC, INSTRUMENTAL AND LABORATORY PARAMETERS OF FEMALE RATS WITH EXPERIMENTAL METABOLIC SYNDROME

2020 ◽  
pp. 20-25
Author(s):  
O. A. Hrygorieva ◽  
Y. V. Korotchuk
Keyword(s):  
Metabolic Syndrome ◽  
Water Regime ◽  
Female Rats ◽  
Control Group ◽  
Laboratory Parameters ◽  
The Metabolic Syndrome ◽  
Calorie Diet ◽  
Experimental Group ◽  
High Calorie Diet ◽  
High Calorie

The aim of the study – to learn the dynamics of changes of morphometric, instrumental and laboratory parameters in mature females rats with experimental metabolic syndrome. Material and Methods. 20 females of white, mature laboratory rats, aged 18–20 months were divided into 2 groups. The first one is an experimental group: 13 female rats with experimental metabolic syndrome; the second one  – control group: 7 intact rats, with standard food and water regime. When working with animals, the standards of the Council of Europe Bioethics Convention 1997, the European Convention for the Protection of Vertebrate Animals were observed. Instruments used during scientific research were subject to metrological control. The simulation of the metabolic syndrome occurred during 60 days. The females supported a special high-calorie diet (grain with margarine 82 % milk fat, corn and sunflower seeds). The water regime included a 20 % solution of fructose and regular water ad libitum, with change every other day. Also, during the first and the fourth weeks of the experiment, the female daily subcutaneously administered Dexamethasone solution at a dosage of 0.1 mg/kg. Results. Since the beginning of the experiment, female rats who received a special high-calorie diet showed a statistically significant increase in all morphometric and instrumental indexes compared to similar rats in the control group. An increase in body weight in the experimental group was found to be 28.93 % higher than the original weight, was observed arterial hypertension (141/85±5) mmHg, dyslipidemia: elevated total cholesterol (5.37±0.33) mmol/L and TG (2.55±0.24) mmol/L; elevated level glucose (8.52±0.17) mmol/L. The above indicators are criteria indicating the presence of metabolic syndrome in animals under study. Conclusions. The proposed model of experimental metabolic syndrome, which includes subcutaneous administration of Dexamethasone solution at a dosage of 0.1 mg/kg in the first and the fourth weeks of experiment, with a special high calorie diet and a 20 % solution of fructose, is an effective way to reproduce the metabolic syndrome in small rodents.

A high calorie diet causes memory loss, metabolic syndrome and oxidative stress into hippocampus and temporal cortex of rats

Synapse ◽  
2015 ◽  
Vol 69 (9) ◽  
pp. 421-433 ◽  
Author(s):  
Samuel Treviño ◽  
Patrícia Aguilar-Alonso ◽  
Jose Angel Flores Hernandez ◽  
Eduardo Brambila ◽  
Jorge Guevara ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Metabolic Syndrome ◽  
Temporal Cortex ◽  
Memory Loss ◽  
Calorie Diet ◽  
And Oxidative Stress ◽  
High Calorie Diet ◽  
High Calorie

Comparative effects of intragastric Lys-Arg-Аrg-Lys-Pro-Gly-Pro peptides, warfarin, and acetylsalicylic acid on hemostasis indexes and blood glucose in development of metabolic syndrome in rats

2021 ◽  
pp. 52-59
Author(s):  
Л.А. Ляпина ◽  
Н.Ф. Мясоедов ◽  
Т.А. Шубина ◽  
Л.А. Андреева ◽  
Т.Ю. Оберган ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Blood Glucose ◽  
Acetylsalicylic Acid ◽  
Prothrombin Time ◽  
Carbohydrate Metabolism ◽  
Intragastric Administration ◽  
Calorie Diet ◽  
Time Test ◽  
High Calorie Diet ◽  
High Calorie

Введение. Препараты разной структуры - углеводной, пептидной, белковой оказывают значительный противосвертывающий эффект в кровотоке с одновременным улучшением углеводного обмена. Цель - изучение в сравнительном аспекте влияния препаратов разной структуры (пептида, производного диоксикумарина и ацетилсалициловой кислоты -АСК) на свертывание крови, изменение углеводного обмена при интрагастральном способе их введении крысам. Методика. Использовались стандартные коагулологические методы и способы определения уровня глюкозы крови крыс. Каждый из препаратов (пептид Lys-Arg-Arg-Lys-Pro-Gly-Pro, варфарин и АСК) вводили лабораторным крысам Wistar интрагастрально в эффективной дозе (100 мкг/кг - пептид и варфарин и 1 мг/кг - АСК) в течение 7 сут на фоне развития метаболического синдрома, индуцируемого высококалорийной диетой (ВКД). Определения производили через 20 и 168 ч после последнего введения препаратов при продолжающемся постоянном кормлении крыс ВКД. Результаты. Установлено, что как через 20 ч, так и через 168 ч после последнего введения пептида и АСК агрегация тромбоцитов имела тенденцию к снижению и составляла 72-76% (через 20 ч) и 81-66,7% (через 168 ч); фибринолиз статистически значимо повышался при действии пептида на 61-180%, АСК - на 15-41%, варфарина - на 14-34%; активированное частичное тромбопластиновое время значимо удлинялось под влиянием пептида и варфарина на 24-52 и 31-52% соответственно; свертывание крови по тесту протромбинового времени снижалось только под влиянием варфарина (на 12.3%); уровень глюкозы крови нормализовался под влиянием всех использованых препаратов и составлял 4,9-6,5 ммоль/л против 8.1-8.8 ммоль/л при метаболическом синдроме. Заключение. При сравнении действия пептида, варфарина и АСК установлены гипокоагуляционные и гипогликемические эффекты в разной степени. Максимальным антикоагулянтным и фибринолитическим действием обладал пептид; варфарин проявлял антикоагулянтное действие только по тесту протромбиновое время, ацетилсалициловая кислота обладала антитромбоцитарным и фибриндеполимеризационным действием. Drugs with different structure, carbohydrates, peptides, and proteins, can produce a significant anticoagulation effect and simultaneously improve carbohydrate metabolism. The aim of this study was to compare effects of drugs with different structure, a peptide, a dioxicoumarin derivative, and acetylsalicylic acid (ASA), on coagulation and changes of carbohydrate metabolism in intragastric administration to rats. Methods. Standard methods for studying coagulation and measuring blood glucose in rats were used. Each of the study drugs (Lys-Arg-Arg-Lys-Pro-Gly-Pro peptide, warfarin, and ASA) was administered to Wistar rats intragastrically at an effective dose (100 mcg/kg for the peptide and warfarin and 1 mg/kg for ASA) for 7 days during the development of metabolic syndrome (MS) induced by a high-calorie diet (HCD). Measurements were performed at 20 and 168 h after the last administration of the drugs with continuing HCD. Results. Both at 20 and 168 h after the last administration of the peptide and ASA, platelet aggregation showed a tendency to a decrease and was 72-76% (at 20 h) and 81-66.7% (at 168 h); fibrinolysis significantly increased under the action of the peptide, ASA, and warfarin by 61-180%, 15-41%, and 14-34%, respectively. Activated partial thromboplastin time significantly increased under the action of the peptide and warfarin by 24-52% and 31-52%, respectively; blood clotting as estimated in the prothrombin time test decreased only under the action of warfarin by 12.3%; blood glucose returned to a normal level under the action of each of the three study drugs and was 4.9-6.5 mmol/l vs. 8.1-8.8 mmol/l in MS. Conclusion. The peptide, warfarin, and ASA produced different degrees of the anticoagulation and hypoglycemic effects. The peptide had the strongest anticoagulation and fibrinolytic effects, warfarin produced an anticoagulant effect only according to the prothrombin time test, and acetylsalicylic acid exerted both antiplatelet and fibrin-depolymerizing effects.

Effect of two hypercaloric diets on the hormonal and metabolic profile of the adrenal gland

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Mokrani Zoulikha ◽  
Zerrouki Nacira ◽  
Gernigon-Spichalowicz Therese ◽  
Soltani Yacine
Keyword(s):  
Adipose Tissue ◽  
Adrenal Gland ◽  
Metabolic Profile ◽  
Visceral Obesity ◽  
Male Adult ◽  
Diet Induced Obesity ◽  
Calorie Diet ◽  
Visceral Adipose ◽  
High Calorie Diet ◽  
High Calorie

Abstract Objectives Who disrupts who? It is not clear what the interaction is between a high calorie diet (HCD) and adrenal axis activation in obesity. The goal was to assess the effect of two hypercaloric diets commercialized in Algeria on the hormonal and metabolic profile of the adrenal gland in rabbits. Methods Two classes of local male adult rabbits (n=16) and a finishing diet (FD) as a control for 15 weeks. Results It has been shown that HCD-received animals have developed visceral obesity, dyslipidemia and insulin resistance IR by dramatically increasing body weight, visceral fat tissue and adrenal weight, combined with elevated plasma levels of ACTH, cortisol, leptin and insulin. The HCD diet increased the levels of cortisol in the visceral adipose tissue (VAT), in peri-adrenal adipose tissue (PAAT), and decreased cortisol levels in the liver. HCD also causes the process of inflammatory fibrosis associated with the migration and spread of chromaffin cells in the adrenal gland. Conclusions This study gives new insights into how diet-induced obesity studied on local rabbits affects the biology of the adrenal gland. The correlation of these changes with paracrine connections between the chromaffin cell and glomerulosa indicates potential therapeutic methods for obese-related steroid hormone dysfunction.

The evaluation of lipid peroxidation and oxidative modification of proteins in blood serum under obesity development and the consumption of aqueous kidney beans Phaseolus vulgaris pods extract

2020 ◽  
Vol 33 (1) ◽  
pp. 38-44
Author(s):  
Alona Yurchenko ◽  
Daryna Krenytska ◽  
Olexii Savchuk ◽  
Tetiana Halenova ◽  
Natalia Raksha ◽  
...  
Keyword(s):  
Lipid Peroxidation ◽  
Oxidative Modification ◽  
Resistance Development ◽  
Oxidative Modification Of Proteins ◽  
Kidney Beans ◽  
Calorie Diet ◽  
Diet Control ◽  
High Calorie Diet ◽  
High Calorie

AbstractOur interest has focused on the investigation of the anti-obese potential of kidney beans (P. vulgaris) pods extract. In the course of the study, obesity development in rats was induced with high-calorie diet. Control and obese rats then have consumed with aqueous kidney beans (P. vulgaris) pods extract during 6 weeks (200 mg/kg). Results show that the long-term consumption of P. vulgaris pods extract can lead to the reduction of hyperglycemia and insulin resistance development. Furthermore, we saw a normalization of lipid peroxidation parameters and oxidative modification of protein due to the consumption of the kidney beans (P. vulgaris) pods extract. Our experimental data demonstrate the ability of the kidney beans (P. vulgaris) pod extracts to mitigate obesity development but the details of this mechanism remains to be not fully understood.

Prevalence of metabolic syndrome in never treated mood disordered patientss

2007 ◽  
Vol 30 (4) ◽  
pp. 95
Author(s):  
Valerie Taylor ◽  
Glenda M. MacQueen
Keyword(s):  
Metabolic Syndrome ◽  
Mood Disorders ◽  
Population Attributable Risk ◽  
Disease Process ◽  
Visceral Obesity ◽  
Premature Mortality ◽  
Overweight And Obesity ◽  
The Metabolic Syndrome ◽  
Increased Risk ◽  
Bipolar Patients

Bipolar disorder and major depression are life-shortening illnesses. Unnatural causes such as suicide and accidents account for only a portion of this premature mortality1 Research is beginning to identify that mood disordered patients have a higher incidence of metabolic syndrome, an illness characterized by dyslipidemia, impaired glucose tolerance, hypertension and obesity.2 Metabolic syndrome is associated with an increased risk for a variety of physical illnesses. Hypothesis: Never treated patients with mood disorders have preexisting elevations in the prevalence of the component variables of metabolic syndrome. Central obesity will be especially elevated, predicting increased premature mortality. Methods: We assessed never treated patients with mood disorders for metabolic syndrome and its component variables. Patients were assessed at baseline and followed up at 6-month intervals. All psychiatric pharmacotherapy was documented. Body mass index (BMI) was also obtained and the percentage of deaths attributable to overweight and obesity was calculated using the population attributable risk (PAR). [PAR= ∑[P (RR-1)/RR] Results: Prior to the initiation of treatment, patients did not differ from population norms with respect to metabolic syndrome or BMI. At 2-year follow-up, BMI had increased for unipolar patients 2.02 points and 1.92 points for bipolar patients. (p < .001) This increase in BMI predicted an increase in mortality of 19.4%. Conclusion: An increase in visceral obesity is often the first component of metabolic syndrome to appear and may indicate the initiation of this disease process prematurely in this group. The increase in BMI places patients with mood disorders at risk for premature mortality and indicates a need for early intervention. References 1.Osby U, Brandt L, Correia N, Ekbom A & Sparen P. Excess mortability in bipolar and Unipolar disorder rin Sweden. Archives of General Psychiatry, 2001;58: 844-850 2.Toalson P, Saeeduddin A, Hardy T & Kabinoff G. The metabolic syndrome in patients with severe mental illness. Journal of Clinical Psychiatry, 2004; 6(4): 152-158

Sign in / Sign up

Export Citation Format

Share Document